Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumor Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06730581
What this trial is testing

Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors

Who this might be right for
Gastric Cancer Adenocarcinoma MetastaticOvarian CancerBile Duct Cancer
Beijing Biostar Pharmaceuticals Co., Ltd. 100
Testing effectiveness (Phase 2)Looking for participantsNCT05684965
What this trial is testing

XTX301 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Xilio Development, Inc. 358
Early research (Phase 1)Ended earlyNCT06560645
What this trial is testing

PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Carcinoma+7 more
Prelude Therapeutics Incorporated 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT06399757
What this trial is testing

Investigate APL-5125 in Adults With Advanced Solid Tumors

Who this might be right for
Colorectal CancerCholangiocarcinomaAppendiceal Adenocarcinoma+6 more
Apollo Therapeutics Ltd 100
Early research (Phase 1)Ended earlyNCT02151357
What this trial is testing

Safety, Tolerability and Pharmacokinetics of DCBCI0901 in Patients With Advanced Solid Tumor

Who this might be right for
Cancer
Standard Chem. & Pharm. Co., Ltd. 17
Testing effectiveness (Phase 2)Ended earlyNCT03361228
What this trial is testing

Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors

Who this might be right for
Solid Tumors
Incyte Corporation 5
Early research (Phase 1)Ended earlyNCT03256331
What this trial is testing

Evaluate the Safety of BEL-X-HG in Advanced Cancer Patients

Who this might be right for
Advanced Solid Tumors
Belx Bio-Pharmaceutical (Taiwan) Corporation 23
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT04868877
What this trial is testing

Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination

Who this might be right for
Non-Small Cell Lung Cancer MetastaticGastric CancerEsophageal Squamous Cell Carcinoma+2 more
Merus B.V. 194
Testing effectiveness (Phase 2)Looking for participantsNCT07288359
What this trial is testing

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Who this might be right for
Advanced HR+/HER2- Breast CancerAdvanced CCNE1-amplified Solid TumorsMetastatic Castration-resistant Prostate Cancer
Novartis Pharmaceuticals 205
Early research (Phase 1)Study completedNCT05864573
What this trial is testing

Study of ZGGS15 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 22
Early research (Phase 1)Study completedNCT02145741
What this trial is testing

Weekly Intravenous Administrations of BI 836845 in Japanese Patients With Advanced Solid Tumours

Who this might be right for
Neoplasms
Boehringer Ingelheim 21
Early research (Phase 1)Ended earlyNCT05427396
What this trial is testing

A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors

Who this might be right for
Liver Cancer, Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Cervical Cancer, MSI-H Colorectal Cancer
Shanghai Junshi Bioscience Co., Ltd. 31
Testing effectiveness (Phase 2)Looking for participantsNCT07380386
What this trial is testing

SKB105 for Injection in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 256
Early research (Phase 1)Study completedNCT02171702
What this trial is testing

Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumours

Who this might be right for
Neoplasms
Boehringer Ingelheim 53
Early research (Phase 1)Study completedNCT00999401
What this trial is testing

Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Cyclacel Pharmaceuticals, Inc. 103
Testing effectiveness (Phase 2)Study completedNCT05407675
What this trial is testing

Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 68
Early research (Phase 1)Ended earlyNCT02049281
What this trial is testing

Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011)

Who this might be right for
Solid Tumor
Endocyte 3
Early research (Phase 1)Ended earlyNCT00375453
What this trial is testing

Dose Escalation Study of SH U04722 in Solid Tumors

Who this might be right for
Tumors
Bayer 10
Early research (Phase 1)Study completedNCT02812875
What this trial is testing

CA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumors and Lymphomas

Who this might be right for
Advanced Solid Tumors or Lymphomas
Curis, Inc. 71
Next Page